Key Record Dates
| ClinicalTrials.gov Identifier: | NCT06056310 |
|---|---|
| Brief Title: | Phase 1b Safety Study of Xevinapant, Weekly Cisplatin, and RT in Participants With Unresected LA SCCHN (HyperlynX) |
| First Submitted : | September 20, 2023 |
| First Submitted that Met QC Criteria : | September 20, 2023 |
| First Posted : | September 28, 2023 |
| Last Update Submitted that Met QC Criteria : | May 10, 2024 |
| Last Update Posted : | May 13, 2024 |